Informed-money record

ANIP · ANI PHARMACEUTICALS INC

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

0

Bearish filings

92

Named actors

32

Disclosed $ (bull / bear)

$0 / $102.4M

Recent disclosures

25 of 92 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-07-13SR. VP, GENERAL COUNSEL & SEC. Cook Meredithsold$41KSEC ↗
2026-07-07Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) PATRICK WALSHfiled notice to sell$374KSEC ↗
2026-07-02SVP & CFO CAREY STEPHEN P.sold$285KSEC ↗
2026-06-29SVP & CFO CAREY STEPHEN P.sold$240KSEC ↗
2026-06-12SR. VP, GENERAL COUNSEL & SEC. Cook Meredithsold$41KSEC ↗
2026-06-08Director HAUGHEY THOMASsold$162KSEC ↗
2026-06-08Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) THOMAS HAUGHEYfiled notice to sell$162KSEC ↗
2026-06-05SVP & CFO CAREY STEPHEN P.sold$265KSEC ↗
2026-06-05Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) STEPHEN P CAREYfiled notice to sell$939KSEC ↗
2026-05-13Director Walsh Patrick Dsold$806KSEC ↗
2026-05-13SR. VP, GENERAL COUNSEL & SEC. Cook Meredithsold$39KSEC ↗
2026-05-13Director (via Charles Schwab Corp) Walsh Patrick Dfiled notice to sell$796KSEC ↗
2026-05-12SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrewsold$36KSEC ↗
2026-05-12SVP, GENERICS Gutwerg Orisold$220KSEC ↗
2026-05-11Director Walsh Patrick Dsold$321KSEC ↗
2026-05-11PRESIDENT & CEO Lalwani Nikhilsold$4.3MSEC ↗
2026-05-11Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) PATRICK WALSHfiled notice to sell$321KSEC ↗
2026-05-11Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) NIKHIL LALWANIfiled notice to sell$4.3MSEC ↗
2026-04-13SR. VP, GENERAL COUNSEL & SEC. Cook Meredithsold$39KSEC ↗
2026-03-19Senior Vice President, Head of Research and Development Muthusamy Shanmugamadopted a selling planSEC ↗
2026-03-13HEAD OF RARE DISEASE Mutz Christophersold$227KSEC ↗
2026-03-13SR. VP, GENERAL COUNSEL & SEC. Cook Meredithsold$36KSEC ↗
2026-03-11SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrewsold$357KSEC ↗
2026-03-09Chairman of the Board of Directors of the Company Thomas J. Haugheyadopted a selling planSEC ↗
2026-03-09HEAD OF RARE DISEASE Mutz Christophersold$267KSEC ↗

67 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals